...
首页> 外文期刊>Arteriosclerosis, thrombosis, and vascular biology >Urotensin-II signaling mechanism in rat coronary artery: Role of STIM1 and Orai1-dependent store operated calcium influx in vasoconstriction
【24h】

Urotensin-II signaling mechanism in rat coronary artery: Role of STIM1 and Orai1-dependent store operated calcium influx in vasoconstriction

机译:大鼠冠状动脉中的降压素II信号转导机制:STIM1和Orai1依赖的钙离子操纵性钙内流在血管收缩中的作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective-: Human urotensin-II (UII) is considered the most potentendogenous vasoconstrictor discovered to date, although the precise mechanism activated downstream of its receptor UTS2R in blood vessels remains elusive. The aim of this study was to determine the role of the store operated Ca 2+ entry (SOCE) signaling pathway in UII-induced coronary artery vasoconstriction. Methods And Results-: We used a combination of isometric tension measurement, Ca 2+ imaging, pharmacology, and molecular approaches to study UII-mediated rat coronary artery vasoconstriction and intracellular Ca 2+ mobilization in coronary smooth muscle cells. We found that UII promoted dose-dependent vasoconstriction and elicited Ca 2+ and Mn influx, which were sensitive to classical SOCE inhibitors. In addition, knockdown of either STIM1 or Orai1 essentially inhibited UII-mediated SOCE and prevented UII but not high-KCL evoked contraction in transfected coronary artery. Moreover, we found that Ca 2+-independent phospholipase A2β was involved in UII effects and that is colocalized with STIM1 in different submembrane compartments. Importantly, STIM1 but not Orai1 downregulation inhibits significantly independent phospholipase A 2 activation. Furthermore, lysophosphatidylcholine, an independent phospholipase A 2 product, activated Orai1 but not STIM1-dependent contraction and SOCE. Conclusion-: Here, we demonstrated that different critical players of SOCE signaling pathway are required for UII-induced vasoconstriction of rat coronary artery.
机译:目标-:迄今为止,尽管人类血管紧张素II(UII)受体UTS2R下游激活的确切机制仍然难以捉摸,但人们认为它是迄今为止发现的最有力的内源性血管收缩药。这项研究的目的是确定存储操作的Ca 2+进入(SOCE)信号通路在UII诱导的冠状动脉血管收缩中的作用。方法和结果-:我们采用等距张力测量,Ca 2+成像,药理学和分子方法相结合的方法,研究UII介导的大鼠冠状动脉血管收缩和冠状动脉平滑肌细胞内Ca 2+动员。我们发现UII促进了剂量依赖性血管收缩并引起了对经典SOCE抑制剂敏感的Ca 2+和Mn流入。此外,敲低STIM1或Orai1实质上抑制了UII介导的SOCE并阻止了UII,但并未抑制高KCL引起的转染冠状动脉收缩。此外,我们发现不依赖Ca 2+的磷脂酶A2β参与UII效应,并且与STIM1共定位在不同的亚膜区室中。重要的是,STIM1但不是Orai1下调抑制了显着独立的磷脂酶A 2激活。此外,溶血磷脂酰胆碱,一种独立的磷脂酶A 2产物,激活了Orai1,但不激活STIM1依赖性的收缩和SOCE。结论-:在这里,我们证明了UII诱导的大鼠冠状动脉血管收缩需要SOCE信号通路的不同关键参与者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号